Echo Therapeutics (ECTE) Announces Common Offering

Echo Therapeutics, Inc. (Nasdaq: ECTE) intends to offer for sale its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Robinhood Ventures Fund II prices IPO at $25 per share on NYSE
• Allogene Therapeutics (ALLO) files $500M mixed shelf
• Londian Wason prices IPO at $22 per ADS, raising $94.3 million